Etomidate Injection, Solution
Product Images NDC 55150-221

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 55150-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))
Etomidate Injection, USP 20 mg per 10 mL (2 mg/mL) solution for intravenous injection, presented as a single dose vial of 10 mL. The label indicates the product is sterile and nonpyrogenic, contains Etomidate USP 2 mg per mL, and includes propylene glycol 35% v/v. Distributed by AuroMedics Pharma LLC, made in India.*
FDA Label Image

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))

Package Label-principal Display Panel (20 mg per 10 mL (2 mg / mL))
Etomidate Injection USP 20 mg per 10 mL (2 mg/mL) intravenous solution in single dose vials. The packaging label shows a box containing 10 vials of 10 mL each, sterile and nonpyrogenic. Distributed by Auro Medics Pharma LLC, the product is for intravenous use only and marked Rx only.*
FDA Label Image

Package Label-principal Display Panel (40 mg per 20 mL (2 mg / mL))

Package Label-principal Display Panel (40 mg per 20 mL (2 mg / mL))
Label for Etomidate Injection, USP 40 mg per 20 mL (2 mg/mL) solution for intravenous use. The single-dose vial contains 20 mL of sterile, nonpyrogenic solution. Distributed by AuroMedics Pharma LLC, made in India. NDC 55150-222-20.*
FDA Label Image

Package Label-principal Display Panel (40 mg per 20 mL (2 mg / mL))

Package Label-principal Display Panel (40 mg per 20 mL (2 mg / mL))
Packaging label for Etomidate Injection, USP 40 mg per 20 mL (2 mg/mL) intravenous solution. The label states it is sterile and nonpyrogenic, intended for intravenous use only. The package contains 10 single-dose vials of 20 mL each. Distributed by Auro Medics Pharma LLC and labeled with NDC 55150-222-20.*
FDA Label Image

Etomidate Chemical Structure (Etomidate Str)

Etomidate Chemical Structure (Etomidate Str)
Chemical structure of Etomidate, showing its molecular arrangement including an imidazole ring, ester linkage, and phenyl group as part of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.